资料摘要
资料下载血管紧张素Ⅱ受体2抗体 Background: Angiotensin II (Ang II) is an important physiological effector of blood pressure and volume regulation through vasoconstriction, aldosterone release, sodium uptake and thirst stimulation. Although Ang II interacts with two types of cell surface receptors, AT1 and AT2, most of the major cardiovascular effects seem to be mediated through AT1. Molecular cloning of the AT1 protein has shown it to be a member of the G protein-associated seven transmembrane protein receptor family. Ang II treatment of cells results in activation of several signal transduction pathways as evidenced by tyrosine phosphorylation of several proteins and induction of others. PLC?is phosphorylated after 30 seconds of treatment with Angiotensin II, indicating this as an early signal transduction event. Ang II treatment also stimulates phosphorylation of Shc, FAK and MAP kinases, and induces MKP-1, indicating stimulation of growth factor pathways. Ang II stimulation through AT1 has been shown to activate the JAK/Stat pathway involving a direct interaction between JAK2 and AT1 as demonstrated by coimmunoprecipitation. The AT1 receptor has no cytoplasmic kinase domain, but is able to function as a substrate for Src kinases and has several putative phosphorylation sites. Also known as: AGTR 2; AGTR2; AGTR-2; AGTR2_HUMAN; angiotensin II receptor type 2; Angiotensin II Type 2; Angiotensin II type-2 receptor; Angiotensin receptor 2; AT 2; AT2; AT2R2 ATGR 2; ATGR2; ATGR-2; MRX 88; MRX88; Type 2 angiotensin II receptor; Type-2 angiotensin II receptor.血管紧张素Ⅱ受体2抗体
大鼠胰岛素(INS)酶联免疫分析试剂盒
简介:大鼠胰岛素(INS)酶联免疫分析试剂盒用于测定大鼠血清,血浆及相关液体样本中胰岛素(INS)含量。本试剂盒仅供研究使用。
大鼠血管内皮生长因子 (VEGF)酶联免疫分析试剂盒
简介:大鼠血管内皮生长因子 (VEGF)酶联免疫分析试剂盒用于测定大鼠血清,血浆及相关液体样本中血管内皮生长因子 (VEGF)含量。
大鼠胸肾表达趋化因子(BRAK/CXCL14)酶联免疫分析试剂盒
简介:大鼠胸肾表达趋化因子(BRAK/CXCL14)酶联免疫分析试剂盒用于测定大鼠血清、血浆及相关液体样本中胸肾表达趋化因子(BRAK/CXCL14)含量。
大鼠纤维蛋白原(FG)酶联免疫分析试剂盒
简介:大鼠纤维蛋白原(FG)酶联免疫分析试剂盒用于测定大鼠血清血浆及相关液体样本中纤维蛋白原(FG)含量。
大鼠纤溶酶原激活物抑制因子(PAI)酶联免疫分析试剂盒
简介:大鼠纤溶酶原激活物抑制因子(PAI)酶联免疫分析试剂盒用于测定大鼠血清、血浆及相关液体样本中纤溶酶原激活物抑制因子(PAI)含量。
相关产品
关注
拨打电话
留言咨询